Kelly Doran
Concepts (487)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Streptococcal Infections | 59 | 2026 | 179 | 20.540 |
Why?
| | Streptococcus agalactiae | 71 | 2026 | 118 | 20.390 |
Why?
| | Vagina | 26 | 2026 | 202 | 9.560 |
Why?
| | Bacterial Proteins | 39 | 2026 | 980 | 4.510 |
Why?
| | Meningitis, Bacterial | 18 | 2026 | 52 | 4.400 |
Why?
| | Blood-Brain Barrier | 21 | 2026 | 169 | 4.210 |
Why?
| | Virulence | 26 | 2026 | 288 | 3.850 |
Why?
| | Bacterial Adhesion | 19 | 2026 | 109 | 2.670 |
Why?
| | Type VII Secretion Systems | 5 | 2024 | 7 | 2.580 |
Why?
| | Adhesins, Bacterial | 12 | 2026 | 46 | 2.450 |
Why?
| | Brain | 20 | 2023 | 2991 | 1.950 |
Why?
| | Candida albicans | 2 | 2026 | 62 | 1.870 |
Why?
| | Mice | 67 | 2026 | 18297 | 1.870 |
Why?
| | Wound Infection | 3 | 2026 | 60 | 1.830 |
Why?
| | Microbial Interactions | 3 | 2026 | 20 | 1.800 |
Why?
| | Disease Models, Animal | 26 | 2026 | 4580 | 1.770 |
Why?
| | Neutrophils | 14 | 2026 | 1133 | 1.720 |
Why?
| | Premature Birth | 4 | 2022 | 390 | 1.630 |
Why?
| | Meninges | 5 | 2026 | 54 | 1.560 |
Why?
| | Animals | 78 | 2026 | 38107 | 1.520 |
Why?
| | Host-Pathogen Interactions | 10 | 2024 | 366 | 1.470 |
Why?
| | Glycolipids | 5 | 2026 | 53 | 1.470 |
Why?
| | Vimentin | 3 | 2022 | 47 | 1.420 |
Why?
| | Community-Institutional Relations | 3 | 2021 | 101 | 1.400 |
Why?
| | Endothelium, Vascular | 9 | 2019 | 952 | 1.290 |
Why?
| | Fimbriae, Bacterial | 6 | 2020 | 36 | 1.250 |
Why?
| | Staphylococcus aureus | 5 | 2026 | 459 | 1.160 |
Why?
| | Antigens, Bacterial | 3 | 2019 | 125 | 1.130 |
Why?
| | Endothelial Cells | 12 | 2026 | 876 | 1.110 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 4 | 2025 | 253 | 1.080 |
Why?
| | Gene Expression Regulation, Bacterial | 14 | 2026 | 340 | 1.070 |
Why?
| | Coinfection | 2 | 2026 | 143 | 1.060 |
Why?
| | Candidiasis, Vulvovaginal | 1 | 2026 | 5 | 0.980 |
Why?
| | Humans | 104 | 2026 | 146342 | 0.970 |
Why?
| | Chemokines | 4 | 2022 | 217 | 0.960 |
Why?
| | Streptococcus | 4 | 2022 | 26 | 0.950 |
Why?
| | Skin | 3 | 2026 | 701 | 0.940 |
Why?
| | Fimbriae Proteins | 4 | 2013 | 25 | 0.940 |
Why?
| | Bacterial Toxins | 5 | 2024 | 110 | 0.910 |
Why?
| | Malassezia | 1 | 2025 | 5 | 0.890 |
Why?
| | Mycobiome | 1 | 2025 | 8 | 0.890 |
Why?
| | Pregnancy | 13 | 2026 | 7230 | 0.870 |
Why?
| | Lactoylglutathione Lyase | 1 | 2025 | 22 | 0.870 |
Why?
| | Reproductive Health | 1 | 2026 | 94 | 0.870 |
Why?
| | Female | 51 | 2026 | 79499 | 0.850 |
Why?
| | Pyruvaldehyde | 1 | 2025 | 46 | 0.840 |
Why?
| | Diabetes Complications | 1 | 2026 | 219 | 0.840 |
Why?
| | Microbiota | 4 | 2026 | 725 | 0.840 |
Why?
| | Cell Line | 19 | 2020 | 2814 | 0.840 |
Why?
| | Leukocyte L1 Antigen Complex | 2 | 2022 | 40 | 0.820 |
Why?
| | Communicable Diseases | 1 | 2026 | 166 | 0.800 |
Why?
| | Teichoic Acids | 3 | 2025 | 21 | 0.760 |
Why?
| | Gene Expression Regulation | 6 | 2021 | 2599 | 0.750 |
Why?
| | Protein Kinases | 3 | 2016 | 311 | 0.750 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2025 | 198 | 0.750 |
Why?
| | Meningitis, Pneumococcal | 2 | 2014 | 7 | 0.750 |
Why?
| | Endothelium | 2 | 2021 | 119 | 0.750 |
Why?
| | Virulence Factors | 9 | 2025 | 175 | 0.740 |
Why?
| | Mutation | 18 | 2026 | 4093 | 0.730 |
Why?
| | Vulnerable Populations | 2 | 2020 | 178 | 0.720 |
Why?
| | Bacterial Outer Membrane Proteins | 1 | 2023 | 58 | 0.720 |
Why?
| | Membrane Lipids | 1 | 2023 | 81 | 0.720 |
Why?
| | Milk, Human | 2 | 2022 | 176 | 0.710 |
Why?
| | Bacillus anthracis | 3 | 2011 | 13 | 0.710 |
Why?
| | Manganese | 1 | 2022 | 59 | 0.710 |
Why?
| | Chorioamnionitis | 1 | 2022 | 50 | 0.700 |
Why?
| | Fibrinogen | 4 | 2019 | 182 | 0.690 |
Why?
| | Enterococcus faecalis | 2 | 2024 | 29 | 0.680 |
Why?
| | Nod2 Signaling Adaptor Protein | 1 | 2021 | 34 | 0.670 |
Why?
| | Practice Patterns, Nurses' | 1 | 2021 | 20 | 0.670 |
Why?
| | Zinc | 2 | 2022 | 310 | 0.660 |
Why?
| | Anthrax | 2 | 2011 | 9 | 0.640 |
Why?
| | Community Health Nursing | 1 | 2020 | 63 | 0.630 |
Why?
| | Minority Groups | 3 | 2021 | 286 | 0.630 |
Why?
| | Hemolysin Proteins | 7 | 2012 | 37 | 0.610 |
Why?
| | Tight Junctions | 4 | 2026 | 87 | 0.610 |
Why?
| | Gram-Positive Bacterial Infections | 1 | 2020 | 72 | 0.600 |
Why?
| | Lipopolysaccharides | 3 | 2025 | 861 | 0.590 |
Why?
| | Inflammation | 4 | 2026 | 2919 | 0.580 |
Why?
| | Assisted Living Facilities | 3 | 2026 | 20 | 0.570 |
Why?
| | Staphylococcal Skin Infections | 2 | 2026 | 40 | 0.560 |
Why?
| | Intimate Partner Violence | 1 | 2020 | 93 | 0.560 |
Why?
| | Biological Products | 1 | 2022 | 258 | 0.550 |
Why?
| | Genome, Bacterial | 4 | 2025 | 122 | 0.540 |
Why?
| | Autophagy | 3 | 2016 | 290 | 0.520 |
Why?
| | Epithelial Cells | 8 | 2026 | 1119 | 0.520 |
Why?
| | Pregnancy Complications, Infectious | 3 | 2019 | 438 | 0.500 |
Why?
| | Oxidoreductases | 2 | 2008 | 91 | 0.490 |
Why?
| | Sepsis | 4 | 2022 | 669 | 0.490 |
Why?
| | Resuscitation Orders | 1 | 2017 | 48 | 0.490 |
Why?
| | Plasmids | 6 | 2009 | 373 | 0.490 |
Why?
| | Infant, Newborn | 9 | 2023 | 6460 | 0.490 |
Why?
| | Peptides | 2 | 2013 | 992 | 0.480 |
Why?
| | Complement C5a | 2 | 2013 | 54 | 0.480 |
Why?
| | Transcriptional Activation | 1 | 2018 | 369 | 0.470 |
Why?
| | Workplace | 1 | 2018 | 268 | 0.470 |
Why?
| | Public Health | 1 | 2021 | 574 | 0.460 |
Why?
| | Health Behavior | 2 | 2019 | 802 | 0.460 |
Why?
| | Astrocytes | 2 | 2015 | 229 | 0.460 |
Why?
| | Interleukin-8 | 5 | 2015 | 268 | 0.460 |
Why?
| | Mutagenesis | 4 | 2025 | 196 | 0.440 |
Why?
| | Staphylococcal Infections | 4 | 2025 | 397 | 0.440 |
Why?
| | Cells, Cultured | 9 | 2021 | 4118 | 0.430 |
Why?
| | Cell Membrane | 2 | 2010 | 701 | 0.410 |
Why?
| | Diabetes Mellitus | 1 | 2023 | 1101 | 0.410 |
Why?
| | Mice, Inbred C57BL | 11 | 2026 | 6034 | 0.400 |
Why?
| | Larva | 1 | 2015 | 242 | 0.400 |
Why?
| | Genitalia, Female | 3 | 2024 | 43 | 0.400 |
Why?
| | Reproductive Tract Infections | 1 | 2013 | 2 | 0.400 |
Why?
| | Neuraminidase | 2 | 2010 | 27 | 0.390 |
Why?
| | Zebrafish | 2 | 2015 | 536 | 0.390 |
Why?
| | Mice, Knockout | 7 | 2026 | 3125 | 0.380 |
Why?
| | MAP Kinase Signaling System | 1 | 2015 | 307 | 0.380 |
Why?
| | Streptococcus pneumoniae | 3 | 2023 | 187 | 0.380 |
Why?
| | Ownership | 2 | 2026 | 116 | 0.370 |
Why?
| | Parasites | 1 | 2013 | 44 | 0.370 |
Why?
| | Gram-Positive Bacteria | 2 | 2023 | 48 | 0.360 |
Why?
| | Gene Expression Profiling | 8 | 2021 | 1792 | 0.360 |
Why?
| | Signal Transduction | 7 | 2015 | 5246 | 0.360 |
Why?
| | Repressor Proteins | 2 | 2013 | 430 | 0.360 |
Why?
| | Integrin alpha2beta1 | 1 | 2011 | 3 | 0.350 |
Why?
| | Health Promotion | 1 | 2018 | 786 | 0.340 |
Why?
| | Health Personnel | 1 | 2018 | 754 | 0.340 |
Why?
| | Mental Disorders | 1 | 2020 | 1148 | 0.340 |
Why?
| | Membrane Glycoproteins | 1 | 2014 | 495 | 0.330 |
Why?
| | Viruses | 1 | 2013 | 165 | 0.330 |
Why?
| | Delay Discounting | 2 | 2022 | 29 | 0.320 |
Why?
| | Bacteria | 2 | 2013 | 766 | 0.320 |
Why?
| | Anti-Bacterial Agents | 4 | 2021 | 1942 | 0.310 |
Why?
| | DNA Replication | 4 | 1999 | 248 | 0.310 |
Why?
| | Phagocytes | 2 | 2008 | 79 | 0.300 |
Why?
| | Poverty | 4 | 2021 | 530 | 0.300 |
Why?
| | Oligosaccharides | 2 | 2022 | 62 | 0.290 |
Why?
| | Immunologic Factors | 1 | 2011 | 244 | 0.290 |
Why?
| | Arachnoid | 2 | 2026 | 15 | 0.290 |
Why?
| | Medically Underserved Area | 2 | 2020 | 102 | 0.280 |
Why?
| | Microcirculation | 2 | 2011 | 142 | 0.280 |
Why?
| | Animals, Newborn | 4 | 2026 | 888 | 0.280 |
Why?
| | Attitude of Health Personnel | 1 | 2017 | 1219 | 0.280 |
Why?
| | Immunity, Innate | 3 | 2016 | 844 | 0.270 |
Why?
| | HIV Infections | 2 | 2020 | 3215 | 0.270 |
Why?
| | Escherichia coli | 5 | 2013 | 832 | 0.260 |
Why?
| | Intestinal Mucosa | 1 | 2013 | 666 | 0.260 |
Why?
| | Operon | 2 | 2023 | 67 | 0.250 |
Why?
| | Transcription Factors | 2 | 2015 | 1730 | 0.250 |
Why?
| | Carrier State | 2 | 2026 | 80 | 0.250 |
Why?
| | DNA Restriction-Modification Enzymes | 1 | 2026 | 3 | 0.240 |
Why?
| | Genomics | 3 | 2022 | 853 | 0.240 |
Why?
| | Substance-Related Disorders | 3 | 2020 | 1100 | 0.240 |
Why?
| | Baltimore | 3 | 2020 | 71 | 0.230 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 3 | 2015 | 846 | 0.230 |
Why?
| | Cardiovascular Diseases | 1 | 2018 | 2219 | 0.230 |
Why?
| | Serotyping | 2 | 2019 | 31 | 0.230 |
Why?
| | Cerebrovascular Circulation | 1 | 2008 | 293 | 0.230 |
Why?
| | Probiotics | 1 | 2026 | 64 | 0.220 |
Why?
| | Adult | 12 | 2026 | 41087 | 0.220 |
Why?
| | Toll-Like Receptor 2 | 1 | 2026 | 125 | 0.220 |
Why?
| | Helicobacter Infections | 2 | 2017 | 30 | 0.220 |
Why?
| | Receptors, Antigen, T-Cell, gamma-delta | 1 | 2025 | 103 | 0.220 |
Why?
| | Perception | 2 | 2018 | 373 | 0.220 |
Why?
| | Mice, Inbred BALB C | 3 | 2019 | 1244 | 0.220 |
Why?
| | Interleukin-17 | 1 | 2025 | 121 | 0.210 |
Why?
| | Uterus | 1 | 2026 | 227 | 0.210 |
Why?
| | Arginine | 1 | 2026 | 264 | 0.210 |
Why?
| | Replication Origin | 3 | 1999 | 17 | 0.210 |
Why?
| | Myeloid Differentiation Factor 88 | 2 | 2017 | 119 | 0.210 |
Why?
| | DNA-Binding Proteins | 4 | 1999 | 1468 | 0.210 |
Why?
| | DNA, Bacterial | 5 | 2004 | 319 | 0.210 |
Why?
| | DNA Transposable Elements | 1 | 2025 | 125 | 0.200 |
Why?
| | Cross-Sectional Studies | 4 | 2026 | 5899 | 0.200 |
Why?
| | DNA-Cytosine Methylases | 1 | 2023 | 3 | 0.200 |
Why?
| | Nursing Homes | 1 | 2026 | 171 | 0.200 |
Why?
| | Colony Count, Microbial | 2 | 2014 | 90 | 0.200 |
Why?
| | Biological Transport | 3 | 2022 | 424 | 0.200 |
Why?
| | Immunity, Cellular | 1 | 2025 | 277 | 0.200 |
Why?
| | Stomach Neoplasms | 2 | 2017 | 128 | 0.200 |
Why?
| | Zonula Occludens-1 Protein | 2 | 2015 | 17 | 0.200 |
Why?
| | Case Management | 2 | 2020 | 66 | 0.200 |
Why?
| | Male | 17 | 2026 | 73396 | 0.190 |
Why?
| | Gastrointestinal Tract | 1 | 2026 | 203 | 0.190 |
Why?
| | Collagen | 1 | 2026 | 460 | 0.190 |
Why?
| | Receptors, Interleukin-8B | 2 | 2013 | 29 | 0.190 |
Why?
| | Pain | 2 | 2026 | 790 | 0.190 |
Why?
| | HeLa Cells | 3 | 2021 | 636 | 0.190 |
Why?
| | Neuroimmunomodulation | 1 | 2023 | 67 | 0.190 |
Why?
| | Keratin-19 | 1 | 2022 | 4 | 0.190 |
Why?
| | Cytokines | 3 | 2026 | 2081 | 0.180 |
Why?
| | Self Efficacy | 1 | 2026 | 418 | 0.180 |
Why?
| | Coxsackievirus Infections | 2 | 2013 | 14 | 0.180 |
Why?
| | Bacteremia | 1 | 2025 | 218 | 0.180 |
Why?
| | Paraquat | 1 | 2022 | 13 | 0.180 |
Why?
| | Meningitis | 2 | 2022 | 80 | 0.180 |
Why?
| | RNA, Bacterial | 2 | 2021 | 183 | 0.180 |
Why?
| | RNA, Small Untranslated | 1 | 2021 | 14 | 0.170 |
Why?
| | Mucins | 1 | 2022 | 75 | 0.170 |
Why?
| | Diseases in Twins | 1 | 2002 | 115 | 0.170 |
Why?
| | Dementia | 1 | 2026 | 324 | 0.170 |
Why?
| | Learning | 3 | 2022 | 446 | 0.170 |
Why?
| | Amino Acid Sequence | 4 | 2015 | 2092 | 0.170 |
Why?
| | Long-Term Care | 2 | 2020 | 118 | 0.170 |
Why?
| | Carcinoembryonic Antigen | 1 | 2021 | 40 | 0.160 |
Why?
| | Glycoproteins | 2 | 2013 | 356 | 0.160 |
Why?
| | Ethanolamine | 1 | 2020 | 6 | 0.160 |
Why?
| | beta Catenin | 1 | 2023 | 250 | 0.160 |
Why?
| | Macrophages | 6 | 2026 | 1532 | 0.160 |
Why?
| | Memory, Short-Term | 2 | 2022 | 276 | 0.160 |
Why?
| | Chemotaxis, Leukocyte | 2 | 2011 | 115 | 0.160 |
Why?
| | Transcription, Genetic | 3 | 2023 | 1432 | 0.160 |
Why?
| | Cigarette Smoking | 1 | 2022 | 103 | 0.160 |
Why?
| | Hydrogen Peroxide | 1 | 2022 | 337 | 0.160 |
Why?
| | Nursing Staff | 1 | 2020 | 41 | 0.160 |
Why?
| | Escherichia coli Proteins | 2 | 1999 | 200 | 0.160 |
Why?
| | Community Medicine | 1 | 2020 | 7 | 0.160 |
Why?
| | Nurse-Patient Relations | 1 | 2020 | 66 | 0.150 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2015 | 974 | 0.150 |
Why?
| | Fluorescent Antibody Technique | 3 | 2016 | 345 | 0.150 |
Why?
| | Cell Adhesion Molecules | 1 | 2021 | 180 | 0.150 |
Why?
| | Disease Susceptibility | 1 | 2021 | 339 | 0.150 |
Why?
| | Drug Resistance, Microbial | 1 | 2019 | 67 | 0.150 |
Why?
| | Molecular Sequence Data | 4 | 2015 | 2838 | 0.150 |
Why?
| | Mucin-5B | 1 | 2022 | 234 | 0.150 |
Why?
| | South Africa | 1 | 2020 | 262 | 0.150 |
Why?
| | Michigan | 1 | 2019 | 203 | 0.150 |
Why?
| | Naloxone | 1 | 2020 | 139 | 0.140 |
Why?
| | Mice, Mutant Strains | 1 | 2019 | 290 | 0.140 |
Why?
| | Students, Nursing | 1 | 2020 | 94 | 0.140 |
Why?
| | Sexual Partners | 1 | 2020 | 195 | 0.140 |
Why?
| | Risk Factors | 4 | 2020 | 10921 | 0.140 |
Why?
| | Vaginosis, Bacterial | 1 | 2018 | 10 | 0.140 |
Why?
| | Phagocytosis | 2 | 2026 | 298 | 0.140 |
Why?
| | Empathy | 1 | 2020 | 184 | 0.140 |
Why?
| | Narcotic Antagonists | 1 | 2020 | 210 | 0.140 |
Why?
| | Homeostasis | 1 | 2022 | 646 | 0.130 |
Why?
| | Students, Health Occupations | 1 | 2018 | 37 | 0.130 |
Why?
| | Antigens, CD | 1 | 2021 | 560 | 0.130 |
Why?
| | Helicobacter pylori | 2 | 2017 | 44 | 0.130 |
Why?
| | Ireland | 1 | 2017 | 33 | 0.130 |
Why?
| | Neonatology | 1 | 2018 | 36 | 0.130 |
Why?
| | Sequence Analysis, RNA | 1 | 2019 | 441 | 0.130 |
Why?
| | Geriatrics | 1 | 2018 | 96 | 0.130 |
Why?
| | Iron | 1 | 2019 | 359 | 0.130 |
Why?
| | Central Nervous System | 2 | 2023 | 278 | 0.120 |
Why?
| | Behavior Therapy | 1 | 2020 | 291 | 0.120 |
Why?
| | Outpatients | 1 | 2020 | 440 | 0.120 |
Why?
| | Choroid Plexus | 2 | 2013 | 5 | 0.120 |
Why?
| | Serine Endopeptidases | 1 | 2017 | 129 | 0.120 |
Why?
| | Microtubule-Associated Proteins | 2 | 2014 | 187 | 0.120 |
Why?
| | Polymerase Chain Reaction | 2 | 2010 | 1031 | 0.120 |
Why?
| | Patient Selection | 1 | 2021 | 728 | 0.120 |
Why?
| | Cell Movement | 2 | 2016 | 951 | 0.120 |
Why?
| | Sheep | 1 | 2019 | 870 | 0.120 |
Why?
| | N-Acetylmuramoyl-L-alanine Amidase | 1 | 2016 | 5 | 0.120 |
Why?
| | Informed Consent | 1 | 2018 | 195 | 0.120 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2019 | 269 | 0.120 |
Why?
| | Genes, Regulator | 1 | 2016 | 34 | 0.120 |
Why?
| | Urban Population | 1 | 2019 | 497 | 0.120 |
Why?
| | Organelle Biogenesis | 1 | 2016 | 14 | 0.120 |
Why?
| | Mast Cells | 1 | 2017 | 150 | 0.120 |
Why?
| | Drug Overdose | 1 | 2020 | 377 | 0.110 |
Why?
| | Claudin-5 | 1 | 2015 | 3 | 0.110 |
Why?
| | Snail Family Transcription Factors | 1 | 2015 | 18 | 0.110 |
Why?
| | Myoblasts | 1 | 2016 | 84 | 0.110 |
Why?
| | Patient-Centered Care | 1 | 2020 | 553 | 0.110 |
Why?
| | Biological Assay | 1 | 2016 | 133 | 0.110 |
Why?
| | Cooperative Behavior | 1 | 2018 | 471 | 0.110 |
Why?
| | Protein Binding | 5 | 2026 | 2244 | 0.110 |
Why?
| | Muscle Development | 1 | 2016 | 114 | 0.110 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2015 | 134 | 0.110 |
Why?
| | Research | 1 | 2018 | 421 | 0.110 |
Why?
| | Coculture Techniques | 1 | 2015 | 245 | 0.110 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2015 | 170 | 0.100 |
Why?
| | Enterovirus B, Human | 1 | 2014 | 25 | 0.100 |
Why?
| | Gene Regulatory Networks | 1 | 2017 | 319 | 0.100 |
Why?
| | Young Adult | 3 | 2021 | 14330 | 0.100 |
Why?
| | Phagosomes | 1 | 2014 | 40 | 0.100 |
Why?
| | Vaginal Diseases | 1 | 2014 | 19 | 0.100 |
Why?
| | Exercise | 1 | 2026 | 2213 | 0.100 |
Why?
| | Virus Shedding | 1 | 2014 | 54 | 0.100 |
Why?
| | Lymphocytic Choriomeningitis | 1 | 2013 | 25 | 0.100 |
Why?
| | Genetic Fitness | 1 | 2014 | 60 | 0.100 |
Why?
| | Integrins | 1 | 2014 | 88 | 0.100 |
Why?
| | Survival Analysis | 2 | 2015 | 1378 | 0.100 |
Why?
| | Serine | 1 | 2014 | 142 | 0.100 |
Why?
| | Recombinant Fusion Proteins | 1 | 2016 | 663 | 0.100 |
Why?
| | Receptor, Anaphylatoxin C5a | 1 | 2013 | 35 | 0.100 |
Why?
| | Immunologic Deficiency Syndromes | 1 | 2013 | 69 | 0.100 |
Why?
| | Bacterial Translocation | 1 | 2013 | 51 | 0.090 |
Why?
| | Cell-Derived Microparticles | 1 | 2014 | 73 | 0.090 |
Why?
| | Protein Transport | 1 | 2014 | 443 | 0.090 |
Why?
| | Epithelium | 1 | 2014 | 295 | 0.090 |
Why?
| | Sequence Alignment | 2 | 2015 | 360 | 0.090 |
Why?
| | Interleukin-1beta | 1 | 2015 | 397 | 0.090 |
Why?
| | Mucus | 1 | 2013 | 75 | 0.090 |
Why?
| | Blotting, Western | 1 | 2015 | 1177 | 0.090 |
Why?
| | Anxiety | 1 | 2020 | 1125 | 0.090 |
Why?
| | Species Specificity | 1 | 2013 | 543 | 0.090 |
Why?
| | Aged | 4 | 2026 | 26432 | 0.090 |
Why?
| | Quality Improvement | 1 | 2021 | 1354 | 0.090 |
Why?
| | Arylsulfotransferase | 1 | 2011 | 3 | 0.090 |
Why?
| | Middle Aged | 6 | 2026 | 36619 | 0.090 |
Why?
| | Neural Stem Cells | 1 | 2013 | 167 | 0.090 |
Why?
| | Bacterial Physiological Phenomena | 1 | 2012 | 47 | 0.090 |
Why?
| | Zebrafish Proteins | 1 | 2015 | 314 | 0.090 |
Why?
| | Phosphoprotein Phosphatases | 1 | 2011 | 67 | 0.090 |
Why?
| | Focal Adhesion Protein-Tyrosine Kinases | 1 | 2011 | 34 | 0.090 |
Why?
| | DNA Primers | 2 | 2009 | 487 | 0.080 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2010 | 752 | 0.080 |
Why?
| | Enterovirus Infections | 1 | 2014 | 175 | 0.080 |
Why?
| | Bacteriophages | 1 | 2013 | 110 | 0.080 |
Why?
| | Cathelicidins | 2 | 2008 | 40 | 0.080 |
Why?
| | Medicaid | 1 | 2015 | 477 | 0.080 |
Why?
| | Flow Cytometry | 1 | 2015 | 1163 | 0.080 |
Why?
| | Immunohistochemistry | 1 | 2015 | 1712 | 0.080 |
Why?
| | Lung | 2 | 2017 | 4122 | 0.080 |
Why?
| | Chemokine CCL20 | 1 | 2010 | 6 | 0.080 |
Why?
| | Antimicrobial Cationic Peptides | 2 | 2008 | 81 | 0.080 |
Why?
| | Chemokine CXCL2 | 1 | 2010 | 41 | 0.080 |
Why?
| | Chemokine CXCL1 | 1 | 2010 | 76 | 0.080 |
Why?
| | Lectins | 1 | 2010 | 44 | 0.080 |
Why?
| | Brazil | 2 | 2021 | 179 | 0.080 |
Why?
| | Neutrophil Infiltration | 1 | 2010 | 107 | 0.080 |
Why?
| | Biomarkers | 1 | 2021 | 4340 | 0.080 |
Why?
| | Microvessels | 1 | 2011 | 98 | 0.080 |
Why?
| | Binding Sites | 4 | 2021 | 1309 | 0.080 |
Why?
| | Cell Wall | 1 | 2010 | 61 | 0.080 |
Why?
| | Biomarkers, Tumor | 1 | 2017 | 1339 | 0.070 |
Why?
| | Bacterial Capsules | 2 | 2026 | 33 | 0.070 |
Why?
| | Mice, Transgenic | 1 | 2014 | 2134 | 0.070 |
Why?
| | Physicians | 1 | 2018 | 955 | 0.070 |
Why?
| | Myeloid Cells | 1 | 2010 | 149 | 0.070 |
Why?
| | Parents | 1 | 2018 | 1394 | 0.070 |
Why?
| | Phosphoproteins | 1 | 2011 | 320 | 0.070 |
Why?
| | Blindness | 1 | 2009 | 51 | 0.070 |
Why?
| | Salmonella typhimurium | 1 | 2010 | 194 | 0.070 |
Why?
| | Placenta | 2 | 2013 | 794 | 0.070 |
Why?
| | Gene Expression | 1 | 2013 | 1463 | 0.070 |
Why?
| | Lactococcus lactis | 1 | 2008 | 2 | 0.070 |
Why?
| | Deafness | 1 | 2009 | 67 | 0.070 |
Why?
| | Microscopy | 1 | 2009 | 147 | 0.070 |
Why?
| | Peer Group | 2 | 2020 | 251 | 0.070 |
Why?
| | Cell Differentiation | 1 | 2016 | 1982 | 0.070 |
Why?
| | Macrophages, Peritoneal | 1 | 2008 | 89 | 0.070 |
Why?
| | Surveys and Questionnaires | 2 | 2018 | 6073 | 0.060 |
Why?
| | Streptolysins | 1 | 2006 | 11 | 0.060 |
Why?
| | Streptococcus pyogenes | 1 | 2006 | 41 | 0.060 |
Why?
| | Drug Resistance, Bacterial | 1 | 2008 | 185 | 0.060 |
Why?
| | Cerebral Palsy | 1 | 2009 | 149 | 0.060 |
Why?
| | Models, Neurological | 1 | 2008 | 252 | 0.060 |
Why?
| | Adolescent | 3 | 2021 | 22557 | 0.060 |
Why?
| | Trophoblasts | 1 | 2008 | 219 | 0.060 |
Why?
| | Neoplasms | 1 | 2021 | 2954 | 0.050 |
Why?
| | Cytotoxins | 1 | 2004 | 15 | 0.050 |
Why?
| | Seizures | 1 | 2009 | 489 | 0.050 |
Why?
| | Membrane Proteins | 1 | 2011 | 1130 | 0.050 |
Why?
| | Cognition Disorders | 1 | 2009 | 559 | 0.050 |
Why?
| | Carotenoids | 1 | 2004 | 47 | 0.050 |
Why?
| | Child | 2 | 2020 | 22693 | 0.050 |
Why?
| | Receptor Activity-Modifying Protein 1 | 1 | 2023 | 2 | 0.050 |
Why?
| | NAV1.8 Voltage-Gated Sodium Channel | 1 | 2023 | 3 | 0.050 |
Why?
| | Emergency Service, Hospital | 1 | 2015 | 2363 | 0.050 |
Why?
| | Nociceptors | 1 | 2023 | 40 | 0.050 |
Why?
| | Calcitonin Gene-Related Peptide | 1 | 2023 | 39 | 0.050 |
Why?
| | DNA Footprinting | 2 | 1999 | 33 | 0.050 |
Why?
| | Fibronectins | 1 | 2022 | 136 | 0.040 |
Why?
| | 1,2-Dipalmitoylphosphatidylcholine | 1 | 2002 | 11 | 0.040 |
Why?
| | Aminoacyltransferases | 1 | 2022 | 13 | 0.040 |
Why?
| | Pain Management | 1 | 2026 | 421 | 0.040 |
Why?
| | Cations | 1 | 2022 | 83 | 0.040 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2026 | 1224 | 0.040 |
Why?
| | Twins, Monozygotic | 1 | 2002 | 133 | 0.040 |
Why?
| | Fatal Outcome | 1 | 2002 | 302 | 0.040 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2022 | 175 | 0.040 |
Why?
| | DNA Methylation | 1 | 2026 | 725 | 0.040 |
Why?
| | Fibroblasts | 1 | 2026 | 1034 | 0.040 |
Why?
| | Cricetulus | 1 | 2021 | 115 | 0.040 |
Why?
| | Aged, 80 and over | 2 | 2026 | 8391 | 0.040 |
Why?
| | CHO Cells | 1 | 2021 | 167 | 0.040 |
Why?
| | GPI-Linked Proteins | 1 | 2021 | 81 | 0.040 |
Why?
| | Treatment Outcome | 2 | 2016 | 11821 | 0.040 |
Why?
| | Cricetinae | 1 | 2021 | 296 | 0.040 |
Why?
| | RNA Stability | 1 | 2021 | 119 | 0.040 |
Why?
| | Drug Resistance, Multiple, Bacterial | 1 | 2021 | 77 | 0.040 |
Why?
| | Age of Onset | 1 | 2002 | 558 | 0.040 |
Why?
| | Chromatography, Liquid | 1 | 2022 | 453 | 0.040 |
Why?
| | Cognitive Remediation | 1 | 2019 | 4 | 0.040 |
Why?
| | Reward | 1 | 2022 | 242 | 0.040 |
Why?
| | Protein Conformation | 2 | 2013 | 916 | 0.040 |
Why?
| | Mutagenesis, Site-Directed | 2 | 2013 | 371 | 0.040 |
Why?
| | Molecular Sequence Annotation | 1 | 2020 | 110 | 0.040 |
Why?
| | Transformation, Genetic | 1 | 1999 | 14 | 0.040 |
Why?
| | Public Health Surveillance | 1 | 2020 | 84 | 0.040 |
Why?
| | Microbial Sensitivity Tests | 1 | 2021 | 367 | 0.040 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 1999 | 90 | 0.040 |
Why?
| | Community Pharmacy Services | 1 | 1999 | 46 | 0.040 |
Why?
| | Drug Therapy | 1 | 1999 | 85 | 0.040 |
Why?
| | Phosphorylation | 2 | 2015 | 1724 | 0.040 |
Why?
| | Residential Facilities | 1 | 2018 | 8 | 0.030 |
Why?
| | Tandem Mass Spectrometry | 1 | 2022 | 576 | 0.030 |
Why?
| | Carrier Proteins | 1 | 2022 | 728 | 0.030 |
Why?
| | Sequence Analysis | 1 | 1998 | 32 | 0.030 |
Why?
| | Models, Molecular | 2 | 2013 | 1574 | 0.030 |
Why?
| | Pharmaceutical Preparations | 1 | 2020 | 172 | 0.030 |
Why?
| | DNA Helicases | 1 | 1999 | 138 | 0.030 |
Why?
| | Enzyme Activation | 1 | 1999 | 759 | 0.030 |
Why?
| | Chymases | 1 | 2017 | 8 | 0.030 |
Why?
| | Disease Progression | 2 | 2017 | 2867 | 0.030 |
Why?
| | Writing | 1 | 2018 | 101 | 0.030 |
Why?
| | Anxiety Disorders | 1 | 2020 | 354 | 0.030 |
Why?
| | Mastitis | 1 | 2016 | 6 | 0.030 |
Why?
| | Phylogeny | 1 | 2020 | 924 | 0.030 |
Why?
| | Genotype | 1 | 2021 | 1879 | 0.030 |
Why?
| | Macrolides | 1 | 2016 | 68 | 0.030 |
Why?
| | Family Practice | 1 | 1999 | 422 | 0.030 |
Why?
| | Rats | 2 | 2016 | 5586 | 0.030 |
Why?
| | Computational Biology | 1 | 2020 | 678 | 0.030 |
Why?
| | Histidine Kinase | 1 | 2015 | 34 | 0.030 |
Why?
| | Emotions | 1 | 2020 | 559 | 0.030 |
Why?
| | Education, Medical | 1 | 2018 | 274 | 0.030 |
Why?
| | Oxidative Phosphorylation | 1 | 2016 | 212 | 0.030 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2016 | 216 | 0.030 |
Why?
| | Mice, Inbred Strains | 1 | 2015 | 384 | 0.030 |
Why?
| | Carbonic Anhydrase II | 1 | 2013 | 4 | 0.030 |
Why?
| | Nestin | 1 | 2013 | 19 | 0.030 |
Why?
| | Communication | 1 | 2020 | 980 | 0.030 |
Why?
| | Osteomyelitis | 1 | 2016 | 148 | 0.030 |
Why?
| | United States | 2 | 2026 | 16136 | 0.020 |
Why?
| | Health Care Surveys | 1 | 2015 | 541 | 0.020 |
Why?
| | Microarray Analysis | 1 | 2013 | 117 | 0.020 |
Why?
| | Gastric Mucosa | 1 | 2013 | 54 | 0.020 |
Why?
| | Social Support | 1 | 2018 | 646 | 0.020 |
Why?
| | Adhesiveness | 1 | 2013 | 18 | 0.020 |
Why?
| | Bacteriophage T4 | 1 | 2013 | 15 | 0.020 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2014 | 145 | 0.020 |
Why?
| | Chronic Disease | 1 | 2019 | 1827 | 0.020 |
Why?
| | X-Ray Diffraction | 1 | 2013 | 76 | 0.020 |
Why?
| | Carbon | 1 | 2014 | 176 | 0.020 |
Why?
| | Models, Immunological | 1 | 2013 | 100 | 0.020 |
Why?
| | Substrate Specificity | 1 | 2013 | 389 | 0.020 |
Why?
| | Sequence Analysis, Protein | 1 | 2012 | 32 | 0.020 |
Why?
| | Cluster Analysis | 1 | 2014 | 496 | 0.020 |
Why?
| | Phenotype | 2 | 2014 | 3206 | 0.020 |
Why?
| | Symbiosis | 1 | 2013 | 71 | 0.020 |
Why?
| | Precancerous Conditions | 1 | 2013 | 162 | 0.020 |
Why?
| | Extracellular Matrix Proteins | 1 | 2013 | 156 | 0.020 |
Why?
| | Decision Making | 1 | 2019 | 993 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2019 | 3647 | 0.020 |
Why?
| | Viral Proteins | 1 | 2014 | 351 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2013 | 834 | 0.020 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2018 | 1763 | 0.020 |
Why?
| | Computer Simulation | 1 | 2016 | 1014 | 0.020 |
Why?
| | Apoptosis | 2 | 2013 | 2439 | 0.020 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2011 | 92 | 0.020 |
Why?
| | Cell Death | 1 | 2012 | 379 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 2012 | 882 | 0.020 |
Why?
| | Qualitative Research | 1 | 2018 | 1734 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2015 | 1242 | 0.020 |
Why?
| | In Situ Hybridization | 1 | 2010 | 317 | 0.020 |
Why?
| | N-Acetylneuraminic Acid | 1 | 2009 | 16 | 0.020 |
Why?
| | Microscopy, Confocal | 1 | 2010 | 322 | 0.020 |
Why?
| | Mitochondria | 1 | 2016 | 997 | 0.020 |
Why?
| | Streptococcal Vaccines | 1 | 2008 | 7 | 0.020 |
Why?
| | Models, Biological | 1 | 2016 | 1761 | 0.020 |
Why?
| | Cell Adhesion | 1 | 2009 | 447 | 0.020 |
Why?
| | Base Sequence | 2 | 2004 | 2123 | 0.020 |
Why?
| | Infant | 1 | 2002 | 10114 | 0.020 |
Why?
| | Genetic Complementation Test | 1 | 2007 | 72 | 0.020 |
Why?
| | Protein Processing, Post-Translational | 1 | 2010 | 487 | 0.020 |
Why?
| | Cysteine Endopeptidases | 1 | 2006 | 81 | 0.010 |
Why?
| | Culture Media | 1 | 2006 | 161 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2013 | 2502 | 0.010 |
Why?
| | Stem Cells | 1 | 2010 | 613 | 0.010 |
Why?
| | Child, Preschool | 1 | 2020 | 11913 | 0.010 |
Why?
| | Proteomics | 1 | 2011 | 1203 | 0.010 |
Why?
| | Hyaluronic Acid | 1 | 2006 | 227 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2012 | 3545 | 0.010 |
Why?
| | Genes, Bacterial | 1 | 2004 | 151 | 0.010 |
Why?
| | Cell Survival | 1 | 2006 | 1105 | 0.010 |
Why?
| | Biomedical Research | 1 | 2008 | 729 | 0.010 |
Why?
| | Reactive Oxygen Species | 1 | 2004 | 610 | 0.010 |
Why?
| | Neurons | 1 | 2010 | 1668 | 0.010 |
Why?
| | Evaluation Studies as Topic | 1 | 1999 | 161 | 0.010 |
Why?
| | England | 1 | 1999 | 106 | 0.010 |
Why?
| | Professional Practice | 1 | 1999 | 58 | 0.010 |
Why?
| | Costs and Cost Analysis | 1 | 1999 | 217 | 0.010 |
Why?
| | Time Factors | 1 | 2007 | 7109 | 0.010 |
Why?
| | Chromosome Mapping | 1 | 1997 | 508 | 0.010 |
Why?
| | Adenosine Triphosphate | 1 | 1997 | 494 | 0.010 |
Why?
|
|
Doran's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|